SCM
INAB icon

Stonepine Capital Management’s IN8bio INAB Stock Holding History

Stonepine Capital Management’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$982K Buy
663,412
+498,519
+302% +$964K 0.39% 35
2025
Q4 		$386K Buy
164,893
+5,472
+3% +$10.4K 0.28% 51
2025
Q3 		$346K Buy
159,421
+76,991
+93% +$169K 0.28% 49
2025
Q2 		$172K Buy
+82,430
New +$335K 0.17% 51

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Stonepine Capital Management's INAB Position: Q1 2026 in Review

Stonepine Capital Management increased its IN8bio (INAB) stake by 302% in Q1 2026, buying an estimated $964K and bringing the position to 663,412 shares worth $982K. The position accounts for 0.39% of the portfolio, ranked #35.

Stonepine Capital Management first reported a position in INAB in Q2 2025 and has held it in 4 quarters since. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • Stonepine Capital Management held 663,412 shares of IN8bio worth $982K as of Q1 2026.
  • Stonepine Capital Management bought 498,519 IN8bio shares in Q1 2026, an estimated $964K.
  • IN8bio made up 0.39% of Stonepine Capital Management's portfolio in Q1 2026, its #35 holding.
  • Stonepine Capital Management first reported a position in IN8bio in Q2 2025 and has held it in 4 quarters since.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Stonepine Capital Management's 13F filing for Q1 2026, filed 14 May 2026.